Weight Loss Drugs Linked to Extra Hair Loss Risk in Men
Summary
A new study from NYU Langone Health shows that weight-loss drugs called GLP-1 medications, like Ozempic and Wegovy, may increase the risk of hair loss in men who are naturally prone to male-pattern baldness. The research found a 7 percent higher risk of this common type of hair loss linked to the genetic effects of these drugs.Key Facts
- GLP-1 drugs help people lose weight and are commonly used by adults with diabetes.
- The study linked increased GLP-1 activity to androgenetic alopecia, the common male-pattern hair loss.
- Researchers analyzed genetic data from over 31,000 people and found a genetic connection between GLP-1 receptor activity and hair loss.
- The increased risk of hair loss was about 7 percent for men genetically predisposed to baldness.
- Hair thinning in GLP-1 users was previously thought to be due to rapid weight loss, but this study suggests a direct biological link.
- The study controlled for other factors like blood pressure, insulin resistance, and testosterone levels.
- Experts say men should not stop their medication but be aware of possible hair loss risks.
- Future screening might help identify people at risk before prescribing GLP-1 drugs.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
